BBSRC Portfolio Analyser
BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments:
UKRI - What we have funded
Investigator / Supervisor details
Name
Dr Rob Riley
Current Institution
AstraZeneca UK Limited
Current Department
R and D Alderley Park
Previous Institutions
Current Awards
No current BBSRC awards
Completed Awards
Reference
Title
Award Role
Value £
Type
01/A2/C/07024
Transcriptional regulation of liver epithelial cell phenotype
Co-Supervisor
39,359
Studentships
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search